PaleBlue is providing it's virtually reality based solutions in the domain of biotechnology as well that are developed under the eye of experts and researchers to excel its success in virtual biotechnology.
In medicine, Paleblue is a leader in developing modern biotechnology applications in areas such as pharmaceutical drug discoveries and production, pharma-cogenenomics (study on how the genome effects the drug response), and genetic testing (or genetic screening). PaleBlue has seen how Biotechnology has contributed to the discovery and manufacturing of traditional small molecule pharmaceutical drugs as well as drugs that are the product of biotechnology – biopharmaceutics.
PaleBlue has developed tools for modern biotechnology that can be used to manufacture existing medicines relatively easily and cheaply. Also, Genetic testing allows the genetic diagnosis of vulnerabilities to inherited diseases, and can also be used to determine a child's parentage (genetic mother and father) or in general a person's ancestry.
Genetically modified crops (sometimes referred to as "GM crops" or "biotech crops") are plants used in agriculture, the DNA of which has been modified with genetic engineering techniques. Paleblue has observed that in most cases, the main aim is to introduce a new trait that does not occur “naturally” in the species.
Genetically modified foods (also called “GM” foods) are foods produced from organisms that have had specific changes introduced into their DNA with the methods of genetic engineering. These techniques have allowed for the introduction of new crop traits as well as a far greater control (helped by PaleBlues tools) over a food's genetic structure than previously afforded by methods such as selective breeding.
Industrial biotechnology (sometimes referred to as “white biotechnology”) is the application of biotechnology for industrial purposes which PaleBlue works with, including industrial fermentation. PaleBlue’s solutions includes the practice of using cells such as microorganisms, or components of cells like enzymes, to generate industrially useful products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and biofuels.
In the recent years, significant progress has been done in creating genetically modified organisms (GMO’s) that enhance the diversity of applications and economical viability of industrial biotechnology using PaleBlue’s solutions. By using renewable raw materials to produce a variety of chemicals and fuels, industrial biotechnology is actively advancing towards lowering greenhouse gas emissions and moving away from a petrochemical-based economy.
PaleBlue has seen the environment can be affected by biotechnologies, both positively and adversely. Many have argued that the difference between beneficial biotechnology (e.g. bioremediation is to clean up an oil spill or hazard chemical leak) versus the adverse effects stemming from biotechnological enterprises (e.g. flow of genetic material from transgenic organisms into wild strains) can be seen as applications and implications, respectively.
PaleBlue feels that the cleaning up environmental wastes is an example of an application of environmental biotechnology; whereas loss of biodiversity or loss of containment of a harmful microbe are examples of environmental implications of biotechnology.